Difficulty: Medium
Average Score: 90%
Practice
What is the appropriate route of administration for insulin?
Correct answer
C
Rationale
Insulin is a peptide hormone that requires precise and controlled delivery to maintain blood glucose levels effectively. The **subcutaneous (C)** route is the standard for most insulin administration because the fatty tissue under the skin provides a slow, consistent absorption rate, which mimics the physiological release of insulin from the pancreas. This route ensures a predictable onset, peak, and duration of action, which is critical for managing diabetes. Subcutaneous injections are also practical for self-administration, with minimal risk of rapid fluctuations in blood sugar levels.
**Intramuscular (A)** injections are inappropriate for routine insulin administration because muscles have a richer blood supply than subcutaneous tissue, leading to faster and less predictable absorption. This could result in hypoglycemia due to rapid insulin uptake. While intramuscular injections may be used in emergencies (e.g., diabetic ketoacidosis), they are not standard for daily management.
**Intradermal (B)** injections are not used for insulin because the dermis lacks sufficient vascularization and fat to ensure consistent absorption. This route is typically reserved for diagnostic tests (e.g., tuberculosis skin tests) or vaccines, where small amounts of fluid are needed and slow absorption is acceptable. Insulin requires reliable absorption kinetics, which intradermal injections cannot provide.
**Intravenous (D)** administration delivers insulin directly into the bloodstream, causing an immediate and sharp drop in blood glucose. This is only appropriate in critical care settings (e.g., severe hyperglycemia or diabetic ketoacidosis) where rapid action is necessary. However, for routine use, intravenous delivery is impractical, dangerous (risk of severe hypoglycemia), and requires continuous monitoring, making subcutaneous the definitive choice for daily insulin therapy.
The subcutaneous routeÔÇÖs balance of safety, efficacy, and ease of use solidifies its role as the standard for insulin administration, while the other routes are either too erratic, impractical, or reserved for specialized scenarios.
**Intramuscular (A)** injections are inappropriate for routine insulin administration because muscles have a richer blood supply than subcutaneous tissue, leading to faster and less predictable absorption. This could result in hypoglycemia due to rapid insulin uptake. While intramuscular injections may be used in emergencies (e.g., diabetic ketoacidosis), they are not standard for daily management.
**Intradermal (B)** injections are not used for insulin because the dermis lacks sufficient vascularization and fat to ensure consistent absorption. This route is typically reserved for diagnostic tests (e.g., tuberculosis skin tests) or vaccines, where small amounts of fluid are needed and slow absorption is acceptable. Insulin requires reliable absorption kinetics, which intradermal injections cannot provide.
**Intravenous (D)** administration delivers insulin directly into the bloodstream, causing an immediate and sharp drop in blood glucose. This is only appropriate in critical care settings (e.g., severe hyperglycemia or diabetic ketoacidosis) where rapid action is necessary. However, for routine use, intravenous delivery is impractical, dangerous (risk of severe hypoglycemia), and requires continuous monitoring, making subcutaneous the definitive choice for daily insulin therapy.
The subcutaneous routeÔÇÖs balance of safety, efficacy, and ease of use solidifies its role as the standard for insulin administration, while the other routes are either too erratic, impractical, or reserved for specialized scenarios.